Trials / Conditions / Metastatic Renal Pelvis and Ureter Urothelial Carcinoma
Metastatic Renal Pelvis and Ureter Urothelial Carcinoma
4 registered clinical trials studyying Metastatic Renal Pelvis and Ureter Urothelial Carcinoma — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Therapeutic Plasma Exchange With Enfortumab Vedotin and Pembrolizumab for Treatment of Bladder Cancers NCT07087860 | Mayo Clinic | Phase 2 |
| Recruiting | Enfortumab Vedotin and Pembrolizumab With Cystectomy and/or Ureterectomy for Locally Advanced or Metastatic Bl NCT06764095 | Mayo Clinic | Phase 4 |
| Completed | Cisplatin and Gemcitabine Hydrochloride With or Without Berzosertib in Treating Patients With Metastatic Uroth NCT02567409 | National Cancer Institute (NCI) | Phase 2 |
| Recruiting | Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate o NCT01050504 | University of Washington | — |